Pure Global
NCT06392516

Ketoacid Analogues Intradialytic Effect on Inflammation

Effect of Intradialytic Administration of Ketoacid Analogues on Inflammatory Parameters in Patients Undergoing Chronic Hemodialysis Twice a Week
RSUP Fatmawati·ClinicalTrials.gov·drugNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Hemodialysis Complication
Drug/Device/Intervention
Ketoacid
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
RSUP Fatmawati
Location
Jakarta, Indonesia
Timeline & enrollment
Phase
N/A
Start date
Apr 29, 2024
End date
Sep 30, 2024
Enrollment
86 participants
Primary outcome

interleukin-6,malnutrition inflammation score,neutrophil lymphocyte ratio,monocyte lymphocyte ratio,thrombocyte lymphocyte ratio

Summary

this study tries to measure the effect of intradialytic ketoacid analogues on inflammatory
 parameters

ICD-10 classifications
Kidney dialysisOther dialysisCare involving dialysisMechanical complication of vascular dialysis catheterHaemoglobinuria due to haemolysis from other external causes
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06392516
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06392516 through Pure Global AI's free database. This phase not specified trial is sponsored by RSUP Fatmawati and is currently Not yet recruiting. The study focuses on Hemodialysis Complication. Target enrollment is 86 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.